Human Genome, GSK Dodge Lupus-Drug Suicide Suit
A Maryland federal judge on Tuesday dismissed a consolidated securities class action accusing Human Genome Sciences Inc. and GlaxoSmithKline PLC of concealing suicide risks associated with lupus drug Benlysta, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article